You are here

  • Home
  • Archive
  • Volume 12, Issue 2
  • Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032)

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032)

 

Online download statistics by month:

Online download statistics by month: March 2024 to March 2026

AbstractFullPdf
Feb 2024775779225
Mar 2024219222107
Apr 202416816969
May 202413814074
Jun 202411611859
Jul 202413913955
Aug 202413313342
Sep 202416016046
Oct 202416216336
Nov 202421521965
Dec 202417117860
Jan 202512712742
Feb 202527227337
Mar 2025979744
Apr 202513813847
May 202524124255
Jun 202513613627
Jul 2025770
Feb 2026110
Total341534411090